Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-410839 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 1, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
90,000
Total Value
$3,476,316.63
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 1, 2026 | Exercise/Conversion | 30,000 | $2.08 | $62,400.00 | 696,568 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 3,525 | $111.44 | $392,826.00 | 693,043 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 5,506 | $112.42 | $618,984.52 | 687,537 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 4,876 | $113.24 | $552,158.24 | 682,661 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 7,601 | $114.43 | $869,782.43 | 675,060 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 8,230 | $115.40 | $949,742.00 | 666,830 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 262 | $116.12 | $30,423.44 | 666,568 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Oct 1, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 60,000 | Direct | โ | View Details |